Concord Drugs Ltd

Concord Drugs Ltd Share Price Today: Live Updates & Key Insights

Get insights on Concord Drugs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Concord Drugs Ltd Share Price Chart

Concord Drugs Ltd Fundamentals

Traded Volume: null

Market Cap(Cr): null

Avg Traded Price null

1 Year return %

Upper Circuit null

Lower Circuit null

P/E TTM 0.00

P/B Ratio 0.00

Traded Value(Cr) null

EPS TTM NaN

Book value NaN

Dividend null%

Concord Drugs Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Concord Drugs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Concord Drugs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W null%

1M null%

3M null%

1Y null%

YTD null%

Concord Drugs Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Concord Drugs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday null

Day Before Yesterday null

1W Avg null

1M Avg null

3M Avg null

Concord Drugs Ltd Technical Details

Concord Drugs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 null

Support 2 null

Support 3 null

Pivot Point : null

Resistance 1 null

Resistance 2 null

Resistance 3 null

Concord Drugs Ltd Corporate Actions

Concord Drugs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Concord Drugs Ltd’s capital allocation strategies.

All

Dividends

No Dividend has been declared by null

Bonus

No Bonus has been declared by null

Splits

No Split has been declared by null

Others

Rights No Rights has been declared by null

Concord Drugs Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Concord Drugs Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Concord Drugs Ltd's relative performance and valuation against major competitors.

Stock Name Sunil Healthcare Ltd ₹75.30 (-3.06%) M. Cap (Cr) 0.77 1 Yr Return (%) -11.93% P/E (TTM) 44.69 PB Ratio 1.14

Stock Name Makers Laboratories Ltd ₹126.00 (-2.59%) M. Cap (Cr) 0.74 1 Yr Return (%) -23.94% P/E (TTM) -3410.01 PB Ratio 1.05

Stock Name Onyx Biotec Ltd ₹40.15 (+2.95%) M. Cap (Cr) 0.73 1 Yr Return (%) NaN% P/E (TTM) 14.69 PB Ratio 1.31

Stock Name Concord Drugs Ltd ₹70.69 (-4.70%) M. Cap (Cr) 0.71 1 Yr Return (%) +85.34% P/E (TTM) 165.63 PB Ratio 2.09

Stock Name Welcure Drugs & Pharmaceuticals Ltd ₹0.55 (+3.77%) M. Cap (Cr) 0.68 1 Yr Return (%) -24.66% P/E (TTM) 2.42 PB Ratio 0.54

Stock Name Asston Pharmaceuticals Ltd ₹77.05 (-3.69%) M. Cap (Cr) 0.66 1 Yr Return (%) NaN% P/E (TTM) 15.29 PB Ratio 5.10

Stock Name Biofil Chemicals & Pharmaceuticals Ltd ₹39.21 (+1.27%) M. Cap (Cr) 0.64 1 Yr Return (%) -42.34% P/E (TTM) 22.79 PB Ratio 3.40

Concord Drugs Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Concord Drugs Ltd, across its operating activities, investing activities, and financing activities.

Concord Drugs Ltd Shareholding Pattern

This shows the ownership breakdown of Concord Drugs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter null%

Public null%

Other Institutions null%

FII null%

Mutual Funds null%

About Concord Drugs Ltd

Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.

Chairman & Managing Director

S Nagi Reddy

Registered office Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511

FAX :91-40-24036379

Background

Incorporation Year 1995

Face Value ₹10.00

Market Lot 1

Concord Drugs Ltd Latest News

VIEW MORE NEWS

FAQs on Concord Drugs Ltd